|Name||Research Grant||Speakers' Bureau/Honoraria/Expert Witness||Stock Ownership/Equity Interests||Consultant/Advisory Board/Steering Committee|
|Robert O. Bonow||None||None||None||Edwards Lifesciences|
|N.A. Mark Estes III||None||Boston Scientific||None||None|
|St. Jude Medical|
|David C. Goff, Jr||None||None||None||None|
|Lee A. Green||None||None||None||None|
|Ann R. Loth||None||None||None||None|
|Frederick A. Masoudi||Amgen⁎||Amgen||None||None|
|Eric D. Peterson||Bristol Myers-Squibb/Sanofi-Aventis⁎||Genentech||None||None|
|Ileana L. Piña||None||AstraZeneca||None||None|
|Martha J. Radford||None||None||None||None|
|John S. Rumsfeld||None||St. Jude Medical||None||Northfield Labs|
|David M. Shahian||None||None||None||None|
This table represents the relationships of committee members with industry and other entities that were reported by the authors as relevant to this topic during the document development process. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity or ownership of $10 000 or more of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted.
ACC indicates American College of Cardiology; and AHA, American Heart Association.
↵⁎ Significant (greater than $10 000) relationship.